Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EP0042 Alone and in Combination With Anti-cancer Treatments in Patients With Advanced Malignancies
NCT04581512Phase 2Recruiting
- Sponsor
- Ellipses Pharma
- Start
- Nov 2020
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of ep0042 in acute myeloid leukemia (AML), chronic myelomonocytic leukemia (CMML), myelodysplastic syndrome (MDS), sponsored by Ellipses Pharma. Started Nov 2020; status: recruiting.
02
Drugs
ep0042
03
Conditions
acute myeloid leukemia (AML)chronic myelomonocytic leukemia (CMML)myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT04581512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04581512.